BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cahill, M T
Right arrow Articles by Fekrat, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cahill, M T
Right arrow Articles by Fekrat, S
Topic Collections
Right arrowRelevant Article
British Journal of Ophthalmology 2003;87:1329-1332
© 2003 BMJ Publishing Group Ltd


SCIENTIFIC REPORT

The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion

M T Cahill1, P K Kaiser2, J E Sears2, S Fekrat1

1 Duke University Eye Center, Erwin Road, PO Box 3802, Durham, NC 27710, USA
2 Cole Eye Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA

Correspondence to:
Correspondence to:
Sharon Fekrat
MD, Duke University Eye Center, Erwin Road, PO Box 3802, Durham, NC 27710, USA; fekra001{at}mc.duke.edu


ABSTRACT
Background: Arteriovenous (AV) sheathotomy, a potential treatment for branch retinal vein occlusion (BVO), surgically separates retinal vessels at an AV crossing. Relief of the aetiological obstruction, with resolution of cystoid macular oedema (CMO), may result in improved visual acuity.

Methods: A retrospective review of consecutive cases of AV sheathotomy for BVO was undertaken. Eyes were categorised as having resolution (group 1), reduction (group 2), or persistence (group 3) of CMO. Intergroup comparisons were made with regard to preoperative, intraoperative, and postoperative parameters. Preoperative and postoperative visual acuities were compared within each group.

Results: Of the 27 eyes identified, eight (29.6%) had resolution, 14 (51.8%) had reduction, and five (18.6%) had persistence of CMO. Median preoperative visual acuity was similar in all groups (1.0, 1.0, 1.3, respectively; p = 0.29). Overall median follow up was 12.0 months (Q1 = 12.0, Q2 = 22.5). Eyes in group 1 had significantly better median postoperative visual acuity than eyes in groups 2 and 3 (0.6, 1.0, 2.0 respectively; p = 0.01). A significantly higher proportion of eyes in group 1 had visual acuity improvement compared with eyes in the other groups (87.5% v 35.7% and 20.0%; p = 0.03). Median postoperative visual acuity was significantly better than median preoperative visual acuity in group 1 eyes only (p = 0.02). A higher percentage of group 1 eyes had evidence of postoperative retinal perfusion (83.0% v 21.43% and 40.0%; p = 0.16). Postoperative retinal detachment occurred in three eyes (11.1%).

Conclusion: Complete resolution of CMO after AV sheathotomy occurred in one third of patients, and postoperative vision improved significantly in this group. However, in the majority of cases, despite an improvement in CMO, there was no improvement in vision after AV sheathotomy.


Keywords: arteriovenous sheathotomy; cystoid macular oedema; branch retinal vein occlusion


Relevant Article

BJO at a glance
Creig Hoyt
Br. J. Ophthalmol. 2003 87: 1309. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
H Shahid, P Hossain, and W M Amoaku
The management of retinal vein occlusion: is interventional ophthalmology the way forward?
Br. J. Ophthalmol., May 1, 2006; 90(5): 627 - 639.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd.